Cargando…
Impact of COVID-19 on clinical outcomes for patients with fractured hip: a multicentre observational cohort study
AIMS: There are reports of a marked increase in perioperative mortality in patients admitted to hospital with a fractured hip during the COVID-19 pandemic in the UK, USA, Spain, and Italy. Our study aims to describe the risk of mortality among patients with a fractured neck of femur in England durin...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The British Editorial Society of Bone & Joint Surgery
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7690757/ https://www.ncbi.nlm.nih.gov/pubmed/33263109 http://dx.doi.org/10.1302/2633-1462.111.BJO-2020-0132.R1 |
_version_ | 1783614141680844800 |
---|---|
author | Rasidovic, Damir Ahmed, Imran Thomas, Christopher Kimani, Peter K-U Wall, Peter Mangat, Karanjit |
author_facet | Rasidovic, Damir Ahmed, Imran Thomas, Christopher Kimani, Peter K-U Wall, Peter Mangat, Karanjit |
author_sort | Rasidovic, Damir |
collection | PubMed |
description | AIMS: There are reports of a marked increase in perioperative mortality in patients admitted to hospital with a fractured hip during the COVID-19 pandemic in the UK, USA, Spain, and Italy. Our study aims to describe the risk of mortality among patients with a fractured neck of femur in England during the early stages of the COVID-19 pandemic. METHODS: We completed a multicentre cohort study across ten hospitals in England. Data were collected from 1 March 2020 to 6 April 2020, during which period the World Health Organization (WHO) declared COVID-19 to be a pandemic. Patients ≥ 60 years of age admitted with hip fracture and a minimum follow-up of 30 days were included for analysis. Primary outcome of interest was mortality at 30 days post-surgery or postadmission in nonoperative patients. Secondary outcomes included length of hospital stay and discharge destination. RESULTS: In total, 404 patients were included for final analysis with a COVID-19 diagnosis being made in 114 (28.2%) patients. Overall, 30-day mortality stood at 14.4% (n = 58). The COVID-19 cohort experienced a mortality rate of 32.5% (37/114) compared to 7.2% (21/290) in the non-COVID cohort (p < 0.001). In adjusted analysis, 30-day mortality was greatest in patients who were confirmed to have COVID-19 (odds ratio (OR) 5.64, 95% confidence interval (CI) 2.95 to 10.80; p < 0.001) with an adjusted excess risk of 20%, male sex (OR 2.69, 95% CI 1.37 to 5.29; p = 0.004) and in patients with ≥ two comorbidities (OR 4.68, CI 1.5 to 14.61; p = 0.008). Length of stay was also extended in the COVID-19 cohort, on average spending 17.6 days as an inpatient versus 12.04 days in the non-COVID-19 group (p < 0.001). CONCLUSION: This study demonstrates that patients who sustain a neck of femur fracture in combination with COVID-19 diagnosis have a significantly higher risk of mortality than would be normally expected. Cite this article: Bone Joint Open 2020;1-11:697–705. |
format | Online Article Text |
id | pubmed-7690757 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | The British Editorial Society of Bone & Joint Surgery |
record_format | MEDLINE/PubMed |
spelling | pubmed-76907572020-11-30 Impact of COVID-19 on clinical outcomes for patients with fractured hip: a multicentre observational cohort study Rasidovic, Damir Ahmed, Imran Thomas, Christopher Kimani, Peter K-U Wall, Peter Mangat, Karanjit Bone Jt Open Hip AIMS: There are reports of a marked increase in perioperative mortality in patients admitted to hospital with a fractured hip during the COVID-19 pandemic in the UK, USA, Spain, and Italy. Our study aims to describe the risk of mortality among patients with a fractured neck of femur in England during the early stages of the COVID-19 pandemic. METHODS: We completed a multicentre cohort study across ten hospitals in England. Data were collected from 1 March 2020 to 6 April 2020, during which period the World Health Organization (WHO) declared COVID-19 to be a pandemic. Patients ≥ 60 years of age admitted with hip fracture and a minimum follow-up of 30 days were included for analysis. Primary outcome of interest was mortality at 30 days post-surgery or postadmission in nonoperative patients. Secondary outcomes included length of hospital stay and discharge destination. RESULTS: In total, 404 patients were included for final analysis with a COVID-19 diagnosis being made in 114 (28.2%) patients. Overall, 30-day mortality stood at 14.4% (n = 58). The COVID-19 cohort experienced a mortality rate of 32.5% (37/114) compared to 7.2% (21/290) in the non-COVID cohort (p < 0.001). In adjusted analysis, 30-day mortality was greatest in patients who were confirmed to have COVID-19 (odds ratio (OR) 5.64, 95% confidence interval (CI) 2.95 to 10.80; p < 0.001) with an adjusted excess risk of 20%, male sex (OR 2.69, 95% CI 1.37 to 5.29; p = 0.004) and in patients with ≥ two comorbidities (OR 4.68, CI 1.5 to 14.61; p = 0.008). Length of stay was also extended in the COVID-19 cohort, on average spending 17.6 days as an inpatient versus 12.04 days in the non-COVID-19 group (p < 0.001). CONCLUSION: This study demonstrates that patients who sustain a neck of femur fracture in combination with COVID-19 diagnosis have a significantly higher risk of mortality than would be normally expected. Cite this article: Bone Joint Open 2020;1-11:697–705. The British Editorial Society of Bone & Joint Surgery 2020-11-04 /pmc/articles/PMC7690757/ /pubmed/33263109 http://dx.doi.org/10.1302/2633-1462.111.BJO-2020-0132.R1 Text en © 2020 Author(s) et al. https://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (CC BY-NC-ND 4.0) licence, which permits the copying and redistribution of the work only, and provided the original author and source are credited. See https://creativecommons.org/licenses/by-nc-nd/4.0/. See https://creativecommons.org/licenses/by-nc-nd/4.0/. |
spellingShingle | Hip Rasidovic, Damir Ahmed, Imran Thomas, Christopher Kimani, Peter K-U Wall, Peter Mangat, Karanjit Impact of COVID-19 on clinical outcomes for patients with fractured hip: a multicentre observational cohort study |
title | Impact of COVID-19 on clinical outcomes for patients with fractured hip: a multicentre observational cohort study |
title_full | Impact of COVID-19 on clinical outcomes for patients with fractured hip: a multicentre observational cohort study |
title_fullStr | Impact of COVID-19 on clinical outcomes for patients with fractured hip: a multicentre observational cohort study |
title_full_unstemmed | Impact of COVID-19 on clinical outcomes for patients with fractured hip: a multicentre observational cohort study |
title_short | Impact of COVID-19 on clinical outcomes for patients with fractured hip: a multicentre observational cohort study |
title_sort | impact of covid-19 on clinical outcomes for patients with fractured hip: a multicentre observational cohort study |
topic | Hip |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7690757/ https://www.ncbi.nlm.nih.gov/pubmed/33263109 http://dx.doi.org/10.1302/2633-1462.111.BJO-2020-0132.R1 |
work_keys_str_mv | AT rasidovicdamir impactofcovid19onclinicaloutcomesforpatientswithfracturedhipamulticentreobservationalcohortstudy AT ahmedimran impactofcovid19onclinicaloutcomesforpatientswithfracturedhipamulticentreobservationalcohortstudy AT thomaschristopher impactofcovid19onclinicaloutcomesforpatientswithfracturedhipamulticentreobservationalcohortstudy AT kimanipeterku impactofcovid19onclinicaloutcomesforpatientswithfracturedhipamulticentreobservationalcohortstudy AT wallpeter impactofcovid19onclinicaloutcomesforpatientswithfracturedhipamulticentreobservationalcohortstudy AT mangatkaranjit impactofcovid19onclinicaloutcomesforpatientswithfracturedhipamulticentreobservationalcohortstudy AT impactofcovid19onclinicaloutcomesforpatientswithfracturedhipamulticentreobservationalcohortstudy |